Skip to main content

Table 3 Univariate and multivariate analyses of prognostic factors for cervical cancer patients

From: Independent prognostic role of human papillomavirus genotype in cervical cancer

Variable

Overall survival

Disease free survival

3-Year Rate

5-Year Rate

P e

Adjusted HR

P b

3-Year Rate

5-Year Rate

P e

Adjusted HR

P f

(95% CI)

(95% CI)

(95% CI) f

(95% CI)

(95% CI)

(95% CI)f

Age, years

 

< 40

93.18 (80.33, 97.75)

93.18 (80.33, 97.75)

0.634

1.00

 

86.43 (72.24, 93.67)

78.58 (62.60, 88.34)

0.956

1.00

 
 

40–50

91.20 (84.67, 95.03)

85.39 (76.26, 91.21)

 

1.74 (0.49, 6.20)

0.390

83.84 (76.07, 89.26)

78.48 (68.81, 85.46)

 

0.72 (0.32, 1.60)

0.417

 

> 50

91.75 (85.20, 95.47)

86.99 (79.22, 92.00)

 

1.09 (0.30, 4.04)

0.893

87.78 (80.55, 92.45)

78.01 (68.46, 84.99)

 

0.56 (0.25, 1.30)

0.177

Histologic typea

 

SCC

91.77 (87.87, 94.46)

87.07 (81.97, 90.81)

0.943

  

85.79 (81.13, 89.37)

77.96 (71.96, 82.82)

0.478

  
 

AC/ASC

87.50 (38.70, 98.14)

87.50 (38.70, 98.14)

   

87.50 (38.70, 98.14)

87.50 (38.70, 98.14)

   

FIGO stageb

 

I

95.82 (89.23, 98.41)

94.73 (87.79, 97.77)

<0.001

1.00

 

93.83 (86.78, 97.18)

86.60 (75.90, 92.76)

<0.001

1.00

 
 

II

95.68 (90.63, 98.04)

88.83 (79.72, 94.00)

 

0.98 (0.27, 3.50)

0.970

89.86 (83.48, 93.87)

84.14 (76.10, 89.65)

 

1.20 (0.43, 3.36)

0.735

 

III

74.66 (59.67, 84.76)

70.20 (54.87, 81.17)

 

3.40 (0.92, 12.52)

0.066

66.66 (51.44, 78.08)

53.52 (37.74, 66.96)

 

4.54 (1.53, 13.42)

0.006

 

IV

60.00 (12.57, 88.18)

40.00 (5.20, 75.28)

 

9.91 (1.87, 52.39)

0.007

16.67 (0.77, 51.68)

16.67 (0.77, 51.68)

 

13.21 (3.24, 53.82)

<0.001

Differentiation

 

Poor

90.36 (81.64, 95.07)

86.83 (76.49,92.82)

0.383

  

83.23 (73.31, 89.71)

68.83 (55.26, 79.03)

0.068

  
 

Moderate

90.68 (83.80, 94.73)

88.08 (80.70,92.77)

   

88.27 (80.98, 92.88)

82.83 (73.70, 89.02)

   
 

Well

90.91 (50.81, 98.67)

72.73 (37.08,90.28)

   

63.64 (29.69, 84.52)

63.64 (29.69, 84.52)

   
 

Unclassified

          

Treatment§

 

Surgery

100

98.53 (90.02, 99.79)

0.004

1.00

 

96.05 (88.24, 98.71)

84.25 (66.36, 93.09)

0.019

1.00

 
 

Surgery plus CT/RT/CRT

100

93.75 (63.23, 99.10)

 

3.98 (0.25, 64.19)

0.331

95.00 (69.47, 99.28)

95.00 (69.47, 99.28)

 

0.43 (0.52, 3.56)

0.433

 

CCRT

90.02 (83.99, 93.87)

82.55 (74.02, 88.49)

 

8.26 (0.87, 78.75

0.066

83.34 (76.34, 88.43)

73.83 (65.27, 80.60)

 

1.44 (0.44, 4.74)

0.545

 

CR or RT

79.55 (64.38, 88.79)

79.55 (64.38, 88.79)

 

13.91 (1.59, 121.54)

0.017

73.37 (57.89, 83.91)

73.37 (57.89, 83.91)

 

1.92 (0.63, 5.88)

0.253

HPV16

 

Negative

83.09 (73.10, 89.63)

81.77 (71.57, 88.60)

0.037

1.00

 

82.89 (72.81, 89.50)

75.71 (64.69, 83.71)

0.342

  
 

Positive

95.17 (91.21, 97.37)

88.93 (82.31, 93.17)

 

0.36 (0.18, 0.74)

0.005

87.07 (81.70, 90.95)

79.03 (71.40, 84.84)

   

HPV18

 

Negative

91.87 (87.80, 94.62)

87.58 (82.23, 91.40)

0.404

  

86.49 (81.69, 90.11)

78.76 (72.58, 83.71)

0.69

  
 

Positive

90.04 (72.14, 96.69)

83.12 (64.02, 92.62)

   

80.85 (62.18, 90.93)

74.63 (52.38, 87.60)

   

HR-HPV speciesd

 

Alpha-7

74.38 (58.47, 84.93)

71.81 (55.65, 82.94)

<0.001

1.00

 

76.32 (60.41, 86.51)

62.96 (45.04, 76.47)

0.005

1.00

 
 

Alpha-9

94.34 (90.44, 96.67)

90.42 (84.82, 94.02)

 

0.17 (0.08, 0.37)

<0.001

87.89 (82.93, 91.47)

80.88 (74.33, 85.92)

 

0.32 (0.17, 0.59)

<0.001

HR-HPV pattern

 

Single

90.90 (86.61, 93.86)

87.04 (81.66, 90.94)

0.939

  

85.47 (80.51, 89.25)

77.41 (71.06, 82.53)

0.389

  
 

Multiple

97.30 (82.32, 99.61)

87.77 (70.52, 95.24)

   

88.83 (72.85, 95.67)

85.54 (68.53, 93.75)

   
  1. aSCC, squamous cell carcinoma; AC, adenocarcinoma; ASC, adeno-squamous carcinoma
  2. bFIGO, International Federation of Gynecology and Obstetrics
  3. cCT, chemotherapy; RT, radiotherapy; CRT, chemoradiotherapy; CCRT, concurrent chemoradiotherapy
  4. dHR-HPV, high risk human papillomavirus
  5. eCalculated by using the log-rank test. Bold values indicate P < 0.05
  6. fAdjusted for age, FIGO stage, and treatment in the Cox regression models